<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Drugs and small molecules against influenza virus that prevent infection with influenza viruses. 
   <bold>[Against Influenza viruses]</bold>
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Hydroxyl antioxidants</th>
    <th>Effect on influenza virus infection</th>
    <th>References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Atorvastatin (Lipitor)</td>
    <td>Inhibition of HMG-CoA reductase</td>
    <td>Episcopio et al. [
     <xref ref-type="bibr" rid="CR229">229</xref>]
    </td>
   </tr>
   <tr>
    <td>Clarithromycin (Biaxin)</td>
    <td>
     <p>Inhibition of MCP-1 and MMP-9,</p>
     <p>Increases of IL6 and IFNgamma</p>
    </td>
    <td>Takahashi et al. [
     <xref ref-type="bibr" rid="CR230">230</xref>]
    </td>
   </tr>
   <tr>
    <td>Flavonoids</td>
    <td>Effect on influenza virus infection</td>
    <td>References</td>
   </tr>
   <tr>
    <td> 5,7,4’-Trihydroxy-8-methoxyflavone</td>
    <td>Inhibition of virus fusion with endosome/lysosome membranes</td>
    <td>Nagai et al. [
     <xref ref-type="bibr" rid="CR231">231</xref>–
     <xref ref-type="bibr" rid="CR235">235</xref>]
    </td>
   </tr>
   <tr>
    <td> Catechins</td>
    <td>
     <p>Inhibition of HA and NA activity</p>
     <p>Inhibition of viral endonuclease activity</p>
    </td>
    <td>
     <p>Song et al. [
      <xref ref-type="bibr" rid="CR188">188</xref>]
     </p>
     <p>Kazuhara et al. [
      <xref ref-type="bibr" rid="CR236">236</xref>]
     </p>
    </td>
   </tr>
   <tr>
    <td> Quercetin 3-rhamnoside</td>
    <td>Reduction of the cytopathic effect (CPE)</td>
    <td>Choi et al. [
     <xref ref-type="bibr" rid="CR237">237</xref>]
    </td>
   </tr>
   <tr>
    <td> Isoquercetin</td>
    <td>Decrease in viral titers</td>
    <td>Kim et al. [
     <xref ref-type="bibr" rid="CR219">219</xref>]
    </td>
   </tr>
   <tr>
    <td> Oligonol (+NAC)</td>
    <td>Inhibition of nuclear export of vRNP</td>
    <td>Gangehei et al .[
     <xref ref-type="bibr" rid="CR238">238</xref>]
    </td>
   </tr>
   <tr>
    <td>Viral enzymes and membrane proteins as targets</td>
    <td>Effect on influenza virus infection</td>
    <td>References</td>
   </tr>
   <tr>
    <td rowspan="4"> Amantadine</td>
    <td>Inhibitor of the matrix protein M2</td>
    <td>Pica and Palese [
     <xref ref-type="bibr" rid="CR239">239</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <p>Selenium nanoparticles with amantadine</p>
     <p>ROS-mediated AKT phosphorylation signal against H1N1</p>
    </td>
    <td>Nabar et al. [
     <xref ref-type="bibr" rid="CR240">240</xref>]
    </td>
   </tr>
   <tr>
    <td>Selenium nanoparticles with ribavirin RNA polymerase inhibitor</td>
    <td>
     <p>Lin et al. [
      <xref ref-type="bibr" rid="CR241">241</xref>]
     </p>
     <p>Li et al. [
      <xref ref-type="bibr" rid="CR161">161</xref>]
     </p>
    </td>
   </tr>
   <tr>
    <td>Activation of the caspase-3 apoptotic pathway against H1N1</td>
    <td>
     <p>Li et al. [
      <xref ref-type="bibr" rid="CR161">161</xref>]
     </p>
     <p>Lin el al [
      <xref ref-type="bibr" rid="CR241">241</xref>].
     </p>
    </td>
   </tr>
   <tr>
    <td> Prion</td>
    <td>
     <p>Protects mice from lethal infection with IAV</p>
     <p>Reduce the ROS in infected lung</p>
    </td>
    <td>Chida et al. [
     <xref ref-type="bibr" rid="CR242">242</xref>]
    </td>
   </tr>
   <tr>
    <td> NS1</td>
    <td>H9N2-NS1 induced ROS and apoptosis</td>
    <td>Qi et al. [
     <xref ref-type="bibr" rid="CR200">200</xref>]
    </td>
   </tr>
   <tr>
    <td> Oseltamivir and zanamivir</td>
    <td>Inhibitor of neuraminidase (NA)</td>
    <td>Kode et al. [
     <xref ref-type="bibr" rid="CR243">243</xref>]
    </td>
   </tr>
   <tr>
    <td> Laninamivir</td>
    <td>Inhibitor of HA</td>
    <td>Tomozawa et al. [
     <xref ref-type="bibr" rid="CR244">244</xref>]
    </td>
   </tr>
   <tr>
    <td> Peramivir</td>
    <td>Inhibitor of HA</td>
    <td>Scott et al. [
     <xref ref-type="bibr" rid="CR245">245</xref>]
    </td>
   </tr>
   <tr>
    <td> Rimantadine</td>
    <td>Inhibitor of M2 ion channel</td>
    <td>Alves Galvão et al. [
     <xref ref-type="bibr" rid="CR246">246</xref>]
    </td>
   </tr>
   <tr>
    <td> NMS-873</td>
    <td>
     <p>Inhibitor of p97 (AAA+ ATPase, VCP)</p>
     <p>Oseltamivir resistant strain specific</p>
    </td>
    <td>Zhang et al. [
     <xref ref-type="bibr" rid="CR247">247</xref>]
    </td>
   </tr>
   <tr>
    <td> Baloxavir marboxil</td>
    <td>Cap-dependent endonuclease inhibitor</td>
    <td>O’Hanlon et al. [
     <xref ref-type="bibr" rid="CR248">248</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <p> 1,3-dihydorxy-6-benzo[C] chromone</p>
     <p> D715-2441 + zanamivir</p>
    </td>
    <td>
     <p>PB2 Inhibitor</p>
     <p>Binding to PBcap</p>
    </td>
    <td>Liu et al. [
     <xref ref-type="bibr" rid="CR249">249</xref>]
    </td>
   </tr>
   <tr>
    <td> Salinomycin + oseltamivir (OSV-P)</td>
    <td>
     <p>M2 channel blocker</p>
     <p>Inhibition of HA</p>
    </td>
    <td>Jang et al., [
     <xref ref-type="bibr" rid="CR250">250</xref>]
    </td>
   </tr>
   <tr>
    <td> 10e (Am2-S31N blocker)</td>
    <td>Proton channel blocker and M2 blocker</td>
    <td>Hu et al. [
     <xref ref-type="bibr" rid="CR251">251</xref>]
    </td>
   </tr>
   <tr>
    <td> Favipiravir</td>
    <td>PB1 inhibitor</td>
    <td>Goldhill et al. [
     <xref ref-type="bibr" rid="CR252">252</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <p> Triple combination of</p>
     <p> Zanamivir + Clarithromycin + Flufenamic acid (FFA)</p>
    </td>
    <td>Inhibitor of HA</td>
    <td>Lee et al. [
     <xref ref-type="bibr" rid="CR253">253</xref>]
    </td>
   </tr>
   <tr>
    <td>Others</td>
    <td>Effect on influenza virus infection</td>
    <td>References</td>
   </tr>
   <tr>
    <td> Single-walled carbon nanotubes (SWCNTs)</td>
    <td>Increasing of H1N1 viral titer</td>
    <td>
     <p>Chen et al. [
      <xref ref-type="bibr" rid="CR254">254</xref>]
     </p>
     <p>Sanpui et al. [
      <xref ref-type="bibr" rid="CR255">255</xref>]
     </p>
    </td>
   </tr>
   <tr>
    <td> Umifenovir</td>
    <td>Interact with HA to inhibit HA</td>
    <td>Chida et al. [
     <xref ref-type="bibr" rid="CR242">242</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
